CASE REPORT OF BELL’S PALSY FOLLOWING SECOND DOSE OF COVISHIELD VACCINE
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i7.44844Keywords:
Bell's palsy, Covishield, ChAdOx1 nCoV-19, Adverse event, pharmacovigilance, Covid ImmunizationAbstract
Bell’s palsy, also known as acute peripheral facial palsy of unidentified reason, is caused by the acute onset of problems with the facial nerve’s lower motor neuron. Several case reports and series have described peripheral facial nerve palsy associated with COVID-19. In addition, since the US food and drug administration’s (FDA) emergency use authorization of several COVID-19 vaccines, there have been media reports of Bell’s palsy associated with vaccination. This case concerns a 26-year-old female with Bell’s palsy (confirmed by clinical diagnosis – an acute unilateral facial nerve paresis or paralysis with onset in >72 h) after receiving second dose of Covishield vaccine (ChAdOx1 nCoV-19). She experienced decreased sleep, dizziness, and left side eye watering post-vaccination. Next day after vaccination, she noticed muscle weakness on the left side of the face, preventing her from close left eye, drinking fluids, and facial droop accompanied by reduced mobility. The patient was treated with methylprednisolone and eye drops (lubricants).
Downloads
References
Yoo MC, Soh Y, Chon J, Lee JH, Jung J, Kim SS, et al. Evaluation of factors associated with favorable outcomes in adults with Bell palsy. JAMA Otolaryngol Head Neck Surg 2020;146:256-63. doi: 10.1001/ jamaoto.2019.4312, PMID 31971554
Cirillo N. Reported orofacial adverse effects of COVID-19 vaccines: The knowns and the unknowns. J Oral Pathol Med 2021;50:424-7. doi: 10.1111/jop.13165, PMID 33527524
Wan EY, Chui CS, Lai FT, Chan EW, Li X, Yan VK, et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: A case series and nested case-control study. Lancet Infect Dis 2022;22:64-72. doi: 10.1016/S1473- 3099(21)00451-5, PMID 34411532
Ministry of Health and Family welfare. About the Vaccine. Government of India: Ministry of Health and Family welfare; 2022. Available from: https://www.mohfw.gov.in/covid_vaccination/vaccination/faqs. html#about-the-vaccine [Last assessed on 2022 Mar 14].
Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij- Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 2020;396:467-78. doi: 10.1016/S0140-6736(20)31604-4, PMID 32702298
Fidler S, Stöhr W, Pace M, Dorrell L, Lever A, Pett S, et al. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): A phase 2, randomised trial. Lancet 2020;395:888-98. doi: 10.1016/S0140-6736(19)32990-3, PMID 32085823
Hanke T. Aiming for protective T-cell responses: A focus on the first generation conserved-region HIV consv vaccines in preventive and therapeutic clinical trials. Expert Rev Vaccines 2019;18:1029-41. doi: 10.1080/14760584.2019.1675518, PMID 31613649
Mothe B, Manzardo C, Sanchez-Bernabeu A, Coll P, Morón-López S, Puertas MC, et al. Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study). EClinicalMedicine 2019;11:65-80. doi: 10.1016/j. eclinm.2019.05.009, PMID 31312806
Fact Sheet for Vaccine Recipient Approved for Restricted Use in Emergency Situation of ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant); 2022. Available from: https://www. seruminstitute.com/pdf/covishield_fact_sheet.pdf [Last assessed on 2022 Mar 12].
Fact Sheet for Vaccine Recipients and Caregivers Restricted Use in Emergency Situation of Covid-19 Covaxin SARS-CoV-2 Vaccine by Bharat Biotech. Available from: https://www.bharatbiotech. com/images/covaxin/covaxin-factsheet.pdf [Last assessed on 2022 Mar 11].
Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 2013;149:S1-27. doi: 10.1177/0194599813505967, PMID 24189771
Published
How to Cite
Issue
Section
Copyright (c) 2022 Raj Kumar, Nagma Bansal, Suleena, Mamta Singh, Amandeep Kaur
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
